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INTRODUCTION
Neonatal porcine Sertoli cells (NPSCs) are known to sur-
vive long-term as discordant xenografts in non-immunosup-
pressed rodents (1). It was previously shown that Setoli cells
(SCs) express complement regulatory proteins (CRPs), which
may exert their effect on the humoral-mediated immune
response (2, 3). Identification of CRPs in SCs suggests that
they can survive complement-mediated cytolysis by pro-
ducing a combination of complement inhibitors, resulting
in protection against destruction by complement activation.
Consistent with these observations, SCs are also known to
produce high levels of clusterin, which has been shown to
inhibit formation of the membrane attack complex (MAC)
in vitro (4). These characteristics of SCs have raised the pos-
sibility that they can be used as candidates for cellular ther-
apy or can be used as vehicles. However, the expression of
CRPs in NPSCs was evaluated only in terms of mRNA lev-
els, and the relative efficiency of CRPs from one species at
regulating complement from a distant species remains a
point of controversy (5, 6).
It is known that SCs exert the local immune environment
via a paracrine interaction with immune cells. They are known
to produce TGFβ , which is suspected to have anti-inflam-
matory properties and is required for an immune-privileged
microenvironment. In fact, TGFβfrom SCs modulates cell
activity and favors Th2 over Th1 cell differentiation, as indi-
cated by the phenotype of the infiltrating T cells in a man-
ner that is dependent on the secretion of TGFβ(7). 
SCs are known to protected themselves from cell-mediat-
ed rejection when transplanted as allografts and xenografts
(8, 9). Additionally, they were able to prevent the rejection
of other cells (10). Although various mechanisms to explain
the local immune-suppressive effect of SCs are under consid-
eration, it remains to be determined whether or how SCs
would modulate a cell-mediated immune response that result-
ed in the induction of systemic tolerance. We can hypothe-
size that immune modulatory mechanisms of SCs can be
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Mechanism of Humoral and Cellular Immune Modulation Provided by
Porcine Sertoli Cells
The understanding of main mechanisms that determine the ability of immune privi-
lege related to Sertoli cells (SCs) will provide clues for promoting a local tolerogenic
environment. In this study, we evaluated the property of humoral and cellular immune
response modulation provided by porcine SCs. Porcine SCs were resistant to human
antibody and complement-mediated formation of the membrane attack complex
(38.41± ±2.77% vs. 55.02± ±5.44%, p=0.027) and cell lysis (42.95± ±1.75% vs. 87.99
± ±2.25%, p<0.001) compared to immortalized aortic endothelial cells, suggesting
that porcine SCs are able to escape cellular lysis associated with complement acti-
vation by producing one or more immunoprotective factors that may be capable of
inhibiting membrane attack complex formation. On the other hand, porcine SCs
and their culture supernatant suppressed the up-regulation of CD40 expression
(p<0.05) on DCs in the presence of LPS stimulation. These novel findings, as we
know, suggest that immune modulatory effects of porcine SCs in the presence of
other antigen can be obtained from the first step of antigen presentation. These
might open optimistic perspectives for the use of porcine SCs in tolerance induc-
tion eliminating the need for chronic immunosuppressive drugs.
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obtained from the first step of antigen presentation. The
induction of the cellular immune response following trans-
plantation involves a complex interaction between antigen
presenting cells (APCs) and T cells. Dendritic cells (DCs),
known to be the most potent of the APCs, play a key role in
directing cellular and humoral immune responses against
self and non-self antigens (11). DCs present endogenously-
expressed antigens as well as exogenous antigens acquired
through endocytic and phagocytic pathways (12). Converse-
ly, DCs can exhibit tolerogenic properties, which seem to
depend directly on their functional state of maturation and
degree of activation (13). In fact, it has been shown that imma-
ture DCs (iDCs) may induce T cell hyporesponsiveness or
regulatory T (Tr) cells (14). This suggests that a strategy to
prevent full activation of DCs during primary sensitization
may be more effective than conventional immunosuppres-
sive agents that broadly inhibit the activation of T lympho-
cytes.
In this study, we tested whether porcine SCs can survive as
xenografts against human antibody- and complement-medi-
ated humoral immune responses in vitro. Also, we tried to
elucidate the effect of porcine SCs on the activation and mat-
uration of DCs in the presence of antigenic stimuli.
MATERIALS AND METHODS
Animals
C57BL/6 male mice, aged 6 weeks, were purchased form
Orient Corporation (Seongnam, Korea) and used as bone
marrow donor at the age of 7-9 weeks. All animal experiments
were performed with approval of the Institutional Animal
Care and Use Committee (IACUC) of Clinical Research
Institute in Seoul National University Hospital. And National
Research Council (NRC) ‘Guidelines for the Care and Use
of Laboratory Animals’ were observed (revised 1996).
Cell lines
Immortalized porcine SC line (NPSCi), was created by
transfection of SV40 large T antigen to NPSCs as previous-
ly reported (3). Immortalized porcine aortic endothelial cell
line (PECi) was a gift from professor Curie Ahn (Seoul Nation-
al University, College of Medicine, Seoul, Korea). They were
maintained in 1:1 mixture of Ham’s F12/DMEM contain-
ing 5% fetal bovine serum (FBS, Gibco Laboratories, Grand
Island, NY, U.S.A.) supplemented with 10 mM HEPES, 5
μ g/mL insulin (Sigma-Aldrich Inc., St. Louis, MO, U.S.A.),
10 μ g/mL transferrin (Sigma-Aldrich Inc.), 10 μ g/mL vitamin
E (Sigma-Aldrich Inc.), 4 μ g/mL hydrocortisone (Sigma-
Aldrich Inc.), and antimycotic/antibiotics (Gibco Laborato-
ries) at 37℃.
Gal expression
Both cell lines, cultured overnight on chamber slides, were
fixed with absolute cold ethanol for 2 hr and stained for Grif-
fonia simplicifolia isolectin B4 (GS-IB4, Molecular Probes Inc.,
OR, U.S.A., 1:100). As a control for nonspecific binding,
cells were also stained as described above without IB4. To
conform the results of immunohistochemistry that are posi-
tive for Gal, 1×106 non-fixed single cells that had been
cultured for 24 hr were incubated with biotin-conjugated
GS-IB4 (1:200) for 30 min on ice, washing twice, fluores-
cein isothiocyanate-conjugated streptavidin (FITC-SA, 1:
500), and analyzed by flow cytometry (FACS).
Binding of human immunoglobulin M
To determine the binding of preformed human xenoreac-
tive antibodies to cell lines, 1×106 non-fixed single cells
after culture for 48 hr were incubated with heat-inactivated
human O serum (iNHS, 50% in staining buffer) for 1 hr at
37℃, followed by monoclonal mouse anti-human IgM (DA-
KO Diagnostics, Carpinteria, CA, U.S.A., 1:50), and FITC-
conjugated rat anti-mouse IgG (Jackson Immuno Research
Lab, Inc., PA, U.S.A., 1:500) for 30 min on ice. Negative
controls were consisted of cells that were incubated in the ab-
sence of human serum. The percentage of cells bound by anti-
human antibodies was determined using FACS analysis.
Membrane attack complex formation
To determine the binding of preformed xenoreactive anti-
bodies to both cell lines, 1×106 non-fixed single cells after
culture for 48 hr were incubated with freshly prepared nor-
mal human O serum (NHS, 50% in staining buffer) for 1 hr
at 37℃, followed by monoclonal mouse anti-human C5b-9
(DAKO Diagnostics, 1:50) and FITC-conjugated rat anti-
mouse IgG (Jackson ImmunoResearch Lab, Inc., 1:500) for
30 min on ice. Negative controls consisted of cells that were
incubated without human serum. The percentage of cells bound
by human antibodies was determined by FACS analysis.
Antibody- and complement-mediated cell lysis
The in vitro human antibody- and complement-mediated
cytotoxicity assay was performed similar to that described
previously (15). Briefly, 4×104 cells were plated in 48-well
tissue culture plates and cultured in 0.5 mL of 1:1 mixture
of Ham’s F12/DMEM (supplemented as above). After 48 hr,
0.1 mL (final 20%) of media were replaced with fresh media
(M), fresh media plus 50 μ L of 3-4 week-old rabbit comple-
ment (M+C, Cedarlane Laboratories Limited, NC, U.S.A.),
iNHS or NHS. Cells were additionally incubated at 37℃for
1 or 4 hr. Each well was washed twice with culture media, and
replaced 0.5 mL fresh culture media. For evaluation of cytotox-516 H.-M. Lee, B.C. Oh, D.-P. Lim, et al.
icity, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetra-
zolium bromide, Sigma-Aldrich Inc.) assay were performed.
Briefly, 50 μ L MTT stock (1 mg/mL in PBS) were added to
each well. After incubation of 4 hr at 37℃ in humidified
CO2 incubator, aspirate the medium containing MTT, and
then add 150 μ L of DMSO to dissolve MTT-formazan crys-
tals. The absorbance of the supernatant was measured at 570
nm using a spectrophotometer with a reference wavelength
of 650 nm. All assays were performed in triplicate with data
expressed as mean absorbance.
Bone marrow-derived DC isolation and culture
Monocytes from bone marrow were differentiated into DCs
in the presence of granulocyte monocyte colony stimulating
factor (GM-CSF) containing culture medium. Briefly, bone
marrow cell suspensions were isolated from femurs of C57BL/
6 mice and propagated in 12-well plates (5×105 cells/well)
in 2 mL RPMI-1640 medium containing antibiotics, 10%
FBS and low-dose GM-CSF (3.5 ng/mL). The culture medi-
um was changed every 2 days. On day 6, loosely adherent cells
were used as resting/immature DCs. Combination of dexam-
ethasone (Dexa, 10-6 M, Sigma-Aldrich Inc.) and active form
of vitamin D3, 1,25(OH)2D3 (D3, 10-10 M, Sigma-Aldrich
Inc.) were added on day 2 and 4 to inhibit maturation of DCs
as reported previously (16) as control. The DCs as iDCs were
tested for surface molecule expressions by FACS analysis.
The effect of porcine SCs on the activation of DCs
The effects of porcine SCs and their culture supernatant
(iSPNT, prepared by 48 hr culture of immortalized porcine
SCs at a density of 5×105 cell/10 mL culture media) on DCs
during activation and maturation were investigated. Briefly,
1×106 iDCs were co-cultured for 24 hr with different ratio
of NPSCi (2×105 or 5×105 in total 3 mL) or iSPNT (1 mL
in total 2 mL) in the presence or absence of lipopolysaccha-
ride (LPS, 1 μ g/mL) stimulation.
FACS
Cells were stained with FITC- or Phycoerythrin (PE)-con-
jugated rat anti-mouse monoclonal antibodies (BD Pharmin-
gen, San Diego, CA, U.S.A.) for CD40 (Cat No. 553723),
CD80 (Cat No. 553768), and MHC II (I-Ab, Cat No. 553551),
or CD11c (Cat No. 553802) after blocking nonspecific bind-
ing with 2.4G2.
Statistical analysis
Data were expressed as mean±SD of n independent exper-
iments. The statistical significance of difference between
multiple comparisons was calculated by one-way analysis of
variance (ANOVA). The Scheffe F-test was used to deter-
mine specific differences between means when determined
as significant by ANOVA. A p value of <0.05 was consid-
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Fig. 1. Expression of Gal-α1,3-Gal (Gal) on immortalized porcine Sertoli (NPSCi) or aortic endothelial (PECi) cells. Cells cultured as a
monolayer on chamber slides and fixed for 2 hr with absolute cold ethanol were immunostained for IB4 lectin (brown). Most of NPSCi (A)
and PECi (B) cells are positive to the Gal epitope. FACS analysis of non-fixed NPSCi (C) and PECi (D) cells stained with FITC-conjugated
IB4 lectin (1:50) for 1 hr to detect Gal (solid line). Also, there are no significant differences in the binding of human IgM to binding of human
xenoreactive antibodies to NPSCi (E, 76.95±6.03%) or PECi (F, 80.76±2.44%) cells (p>0.05). 
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ered significant.
RESULTS
Gal expression
Graft rejection mediated by antibody recognition of the
Gal epitope is a major barrier in porcine to human xenotrans-
plantation. Both NPSCi and PECi cells, cultured on cham-
ber slides, were found to express Gal. The staining intensity
on NPSCi cells was similar to that of PECi cells (Fig. 1A, B).
Almost all of the NPSCi and PECi cells were Gal positive
on analysis with non-fixed single cells by FACS (Fig. 1C, D).
This suggests that nearly all of the cells expressed Gal.
Binding of human preformed xenoreactive antibodies
The expression of Gal on the surface of NPSCi and PECi
cells suggests that they may be recognized by antibodies pre-
sent in human serum. Therefore, we examined the binding
of human IgM on cells using FACS analysis. When cells were
incubated with 50% heat-inactivated human type O serum,
NPSCi and PECi cells were 76.95±6.03% and 80.76±
2.44% positive for human IgM binding, respectively (Fig.
1E, F). No statistical significance was observed (p>0.05).
This suggested that the majority of the cells were reactive
to human antibodies.
MAC formation
Cells were examined for the formation of MAC by the
human antibody and complement system. In contrast to the
similar binding of human IgM, NPSCi and PECi cells were
38.41±2.77% and 55.02±5.44% positive for MAC (Fig.
2). MAC formation was significantly lower in NPSCi cells
compared to PECi cells (p=0.027). This suggests that NPSCi
cells can survive against humoral immune rejection by inhibit-
ing the formation of MAC.
Antibody- and complement-mediated cell lysis
Although the binding of human IgM did not show sig-
nificant differences between NPSCi and PECi cells, MAC
formation was significantly reduced in NPSCi cells. There-
fore, we examined whether there are differences in suscepti-
bility to human natural antibody- and complement-medi-
ated lysis between NPSCi and PECi cells using MTT assays
(Fig. 3). After 1 hr exposure to human serum in the presence
or absence of complement, there were no significant differ-
ences in cell lysis between NPSCi and PECi cells, but expo-
sure to normal human serum significantly accelerated the
lysis of both cell lines. After 4 hr exposure to heat-inactivat-
ed human serum, both cell lines were lysed to some extent
but there were no significant differences between cell lines
(p>0.05). The percentage of viable NPSCi and PECi cells was
not dependent on the length of exposure to heat-inactivated
human serum. In contrast, there was a significant decrease
in viable PECi cells (12.01±2.50% survival) after incuba-
tion with normal human serum. However, NPSCi cells were
dramatically resistant to cell lysis compared to PECi cells in
the presence of complement (p=0.007). While the viable PECi
cells were significantly decreased at 4 hr exposure to normal
human serum compared to 1 hr exposure, there was no sig-
nificant change in the number of viable NPSCi cells.
The effects of porcine SCs on the activation of DCs
LPS stimulation strongly increased the expression of sur-
face molecules on DCs such as costimulatory molecules
(CD40 and CD80) and MHC II (I-Ab) compared to iDCs
(Fig. 4, 5). The increased expression of surface molecules
was not found in the abnormally differentiated DCs follow-
ing the addition of Dexa and D3 (Fig. 4). The addition of
Dexa and D3 during initial differentiation from monocytes
to DCs strongly decreased the yields of DCs (data not shown)
and significantly reduced the expression of I-Ab in the pres-
ence of LPS stimulation (data not shown). Co-culture with
NPSCi cells did not promote the activation of DCs compar-
ed to their activation in the presence of LPS (Fig. 4). This
Fig. 2. Formation of membrane attack complex (MAC) on the
immortalized porcine Sertoli (NPSCi, A, 38.41±2.77%) and aor-
tic endothelial (PECi, B, 55.02±5.44%) cells in the presence of
normal human serum. Both cell lines show the significant differ-
ence in the formation of MAC (p=0.027). Gray histograms corre-
spond to the control cells that were not pre-incubated with human
serum, and solid histograms represent specific staining of human
C5b-9. The data are presented as mean±SD of three individual
experiments in triplicate.
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may suggest that NPSCi cells are ignored by xenogeneic
DCs and are able to escape the xenogeneic cell-mediated
immune response. In contrast, NPSCi cells suppressed the
expression of CD40 on DCs even in the presence of LPS.
Such suppression of CD40 expression on DCs was not affect-
ed by the NPSCi cells:DCs ratio (1:4 or 1:2).
A significant reduction in the expression of CD40 was
also observed upon the addition of iSPNT in the presence of
LPS compared to the expression in DCs co-cultured with
iSPNT (Fig. 5), which showed a correlation with down-reg-
ulation of CD40 expression. These findings suggest that the
suppressive effect, shown in a co-culturing experiment, is
not dependent on the starvation by added competitor cells.
Meanwhile, NPSCi cells and iSPNT did not significantly
modulate the expression of CD80 and I-Ab on DCs in the
presence of LPS stimulation.
DISCUSSION
In this study, we tested whether NPSCi cells can survive
as xenografts against human antibody- and complement-
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Fig. 3. Susceptibility of immortalized porcine Sertoli (NPSCi) or aortic endothelial (PECi) cells to human natural antibody- and comple-
ment-mediated lysis. Negative control values (media alone) for NPSCi and PECi cells were arbitrarily set equal to 100%, and the relative
percentage of cell viability was calculated for each condition. The data are presented as the mean±SD of three individual experiments
in triplicate. Means bearing different superscript letters are significantly different at p<0.05. 
M, media alone; M+C, media+rabbit complement; iNHS, heat-inactivated normal human serum; NSH, normal human serum.
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mediated humoral immune responses in vitro. Additionally,
the effects of NPSCi cells and iSPNT on the activation and
maturation of xenogeneic mouse bone marrow-derived DCs
were evaluated.
Although both NPSCi and PECi cells expressed Gal simi-
larly and human IgM reacted with these cells (Fig. 1), NPSCi
cells were dramatically resistant to cell lysis compared to
PECi cells in the presence of complement as compared to
the protective effects of down-regulation of Gal on porcine
endothelial cells by RNA interference to protect them from
the humoral immune response (17). These results raised the
possibility that NPSCi cells can be used as vehicles. The abil-
ity of NPSCi cells to survive human antibody- and comple-
ment-mediated lysis could be an active process due to the
production of immunoprotective factors by SCs. This would
suggest that NPSCi cells are able to survive against comple-
ment activation by producing one or more immunoprotec-
tive factors that may be able to inhibit formation of MAC
because MAC formation was significantly inhibited (Fig. 2).
Consistent with this observation, SCs are also known to pro-
duce clusterin (2, 3), which has been shown to inhibit forma-
tion of the MAC in vitro (18). An alternative mechanism is
that NPSCi cells survive complement-mediated cytolysis by
producing a combination of complement inhibitors. In addi-
tion to clusterin, SCs have been shown to produce many
immunoprotective factors such as mRNA for complement
inhibitors such as the membrane cofactor protein (MCP),
protectin (CD59), and decay-accelerating factor (DAF). Pre-
viously, it was speculated that complement inhibitors are
species-specific, and therefore, porcine complement inhibitors
expressed by porcine tissues may be unable to inhibit human
complement cytolysis. However, more recent studies indicate
that porcine MCP, CD59, and DAF are all effective in inhibit-
ing human complement at least in vitro (5, 6, 19-23).
In general, successful initiation of the cellular immune
response requires the activation and maturation of DCs, ins-
truction of naive T cells, and coordination of the primary
immune response. However, our results showed that NPSCi
cells can suppress the activation and maturation of DCs in
the presence of LPS stimulation, suggesting their skew towards
an immature or inadequate maturation status. Co-culturing
with NPSCi cells or the addition of iSPNT induced impair-
ed maturation of DCs in the presence of LPS stimulation, as
shown by suppressed expression of CD40, which is needed
for normal antigen presentation to produce an immune res-
ponse. These novel findings, as we know, provide new insight
into the immunopharmacological role of soluble factors from
NPSCi cells in impacting the DCs. It is well known that
when antigen presentation occurs in the absence of costimu-
lators, a state of anergy can develop, or the preferential induc-
tion of antibody-inducing Th2 responses may arise (24).
Expression of CD40 on DCs is an especially important fac-
tor that determines whether priming will result in immu-
nity or tolerance (25). Antigen-exposed DCs that lack CD40
prevent T cell priming, suppress previously primed immune
responses, and induce IL-10 secreting CD4 Tr cells that can
transfer antigen-specific tolerance to primed recipients (26).
Additionally, a lack of activation of CD40 on DCs by CD40L-
defective anergic cells might be the primary event involved
in T cell suppression and supports the role of CD40 signaling
in regulating both the activation and survival of DCs (27).
Although the mechanisms responsible for these phenom-
ena are not clear, we can consider the soluble factors secreted
by SCs. We previously found that NPSCi cells express TGF
β 1 and IL-6 (2), which are known to confer tolerogenic prop-
erties to DCs and to inhibit development of DCs (28) or lead
to the generation of phenotypically mature but functionally
impaired DCs (29).
In conclusion, our results raised the possibility that NPSCi
cells can be engineered using transgenic technology to pro-
duce useful proteins or can be used as a vehicle. NPSCi cells
can also convert APCs into an inhibitory or suppressor phe-
notype via secreting immune modulatory proteins, thus lock-
ing them into a semi-mature state, thereby resulting in an
attenuated or regulatory T cell response. This opens opti-
mistic perspectives for the use of porcine SCs for modula-
tion of cell-mediated immune responses compared to previ-
ous DC-based tolerance induction technologies that have
limitations including the debilitating consequences of the
use of lifelong immunosuppressant regimens. More studies
are needed to address the in vivo effect of porcine SCs on the
induction of peripheral tolerance.
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